Sign up today to learn more about Pear Therapeutics stock
Pear Therapeutics Stock
Prescription Digital Therapeutics
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts.
Bridge Builders Collaborative
Chief Executive Officer
Chief Financial & Operating Officer
fiercebiotech - Nov, 18 2020
news - Nov, 5 2020
bioworld - Sep, 22 2020
BioSpace - Jan, 13 2020